Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BioNTech SE    BNTX

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/12/2021 01/13/2021 01/14/2021 01/15/2021 01/19/2021 Date
105.45(c) 102.61(c) 105.85(c) 101.59(c) 105.1 Last
3 560 296 1 816 018 1 910 243 3 151 568 1 833 383 Volume
-3.17% -2.69% +3.16% -4.02% +3.46% Change
More quotes
Financials
Sales 2020 497 M 603 M 603 M
Net income 2020 -329 M -399 M -399 M
Net cash position 2020 936 M 1 135 M 1 135 M
P/E ratio 2020 -67,9x
Yield 2020 -
Sales 2021 6 507 M 7 889 M 7 889 M
Net income 2021 4 445 M 5 389 M 5 389 M
Net cash position 2021 4 339 M 5 261 M 5 261 M
P/E ratio 2021 5,44x
Yield 2021 -
Capitalization 20 258 M 24 461 M 24 560 M
EV / Sales 2020 38,9x
EV / Sales 2021 2,45x
Nbr of Employees 1 800
Free-Float 92,4%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Notations Surperformance© of BioNTech SE
Trading Rating : Investor Rating :
More Ratings
All news about BIONTECH SE
03:10pU.S. exceeds 400,000 coronavirus deaths
RE
11:35aBrussels targets vaccinating at least 70% of EU adults by summer
RE
08:55aEuropean countries struggle to make most of Pfizer COVID-19 vaccine doses
RE
07:46aEuropean countries struggle to make most of Pfizer COVID-19 vaccine doses
RE
06:47aEngland Hospitals Use Google-IBM Blockchain Technology To Store Vaccines
MT
04:28aPfizer Asked by New York Gov. Cuomo if State Can Directly Purchase COVID-19 V..
MT
01/18Britain Faces COVID-19 Vaccine Supply Delays, Remains On Course To Achieve Va..
MT
01/18Mexico aims to make up for Pfizer vaccine shortfall with others
RE
01/18Mexico aims to make up for Pfizer vaccine shortfall with others
RE
01/18BIONTECH : Norway Warns Against Vaccinating the Terminally Ill
DJ
01/18Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout
RE
01/18Norway says advice on use of Pfizer vaccine is unchanged
RE
01/18Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout
RE
01/18WHO says close to Pfizer deal that would give poorer countries access
RE
01/18BIONTECH SE : - Statement on European Upscaling as well as Impact on Deliveries
AQ
More news
News in other languages on BIONTECH SE
11:21aWDH/EU-Kommission will 70 Prozent Corona-Impfrate bis zum Sommer
11:10aKommende Woche vorübergehend weniger Biontech-Impfstoff
09:37aWENIGER IMPFSTOFFLIEFERUNGEN :  Zweitimpfung bleibt meist gewährleistet
09:15aAfrika bereitet sich auf erste Corona-Impfkampagnen vor
05:07aGesundheitsministerium beantwortet SPD-Fragenkatalog zum Impfen
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 92,65 €
Last Close Price 84,13 €
Spread / Highest target 32,0%
Spread / Average Target 10,1%
Spread / Lowest Target -31,6%
EPS Revisions
Managers and Directors
NameTitle
Ugur Sahin Chief Executive Officer
Helmut Jeggle Chairman-Supervisory Board
Sierk Pötting Chief Operating & Financial Officer
Özlem Türeci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE24.62%24 461
GILEAD SCIENCES, INC.8.70%79 386
VERTEX PHARMACEUTICALS-4.57%58 652
REGENERON PHARMACEUTICALS7.21%54 665
WUXI APPTEC CO., LTD.6.43%53 924
BEIGENE, LTD.33.52%31 458